Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT by Frozen Stool Capsules for Pediatric Ulcerative Colitis
NCT05202990Phase 2Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2026
- Primary completion
- Jul 2028
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Fecal Microbiota Transplantation Capsule in ulcerative colitis (UC) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Increase in the richness of the recipient's microbiota at 12 months. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT05202990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05202990.